Skip to main content
Clinical Trials/IRCT20150726023349N4
IRCT20150726023349N4
Recruiting
未知

Comparison evaluation of sleep disorders incidence in patients with primary breast cancer admitted to Imam Khomeini hospital in Tehran received melatonin during adjuvant chemotherapy

Tehran University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast cancer.
Sponsor
Tehran University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are in stage one to three breast cancer and cancer surgery is performed within the last three months.
  • No history of prior chemotherapy
  • No contraindication for adjuvant chemotherapy of breast cancer (including heart failure and drug hypersensitivity)
  • 40 to 60 years old at the onset of chemotherapy
  • The absence of uncontrolled diabetes and renal failure with glomerular filtration less than 30

Exclusion Criteria

  • Delay or discontinuation of chemotherapy over one month for any reason
  • Sleep disorder, depression and anxiety requiring drug treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials